Hattie Webster
|
 |
Fluoxetine ( Prozac ), Sertraline HCL ( Zoloft )) and novel antidepressant drugs (Mirtazapine ( Remeron ), nefazodone) on the activity of CYP2D, measured as a rate of ethylmorphine O-deethylation. Although this suggests a role for central beta1-adrenergic receptors in internet pharmacies no prescription the mechanism of action of certain antidepressant online pharmacy drugs, it does not seem that stimulation of these receptors is an effect shared by antidepressants from all pharmacological classes. The obtained results indicate three different mechanisms of the antidepressants-CYP2D interaction. Rats were trained to discriminate centrally administered isoproterenol (10 microg i.c.v.) from artificial cerebral spinal fluid using a water-reinforced, two-lever operant task (fixed ratio online pharmacy 10 schedule). Effects of antidepressants in rats trained to discriminate centrally administered isoproterenol.Previous work has proven that the discriminative stimulus effects of centrally administered isoproterenol are mediated primarily via beta1-adrenergic receptors. Desipramine and yasmin clomipramine did not produce any effect when administered in-vivo. After acquisition of the discrimination, drugs were tested for substitution (i.p.). After prolonged administration of antidepressants, the decreased CYP2D activity produced by imipramine, Fluoxetine ( Prozac ) and Sertraline cialis HCL ( Zoloft )was still maintained. Moreover, Amitriptyline ( Elavil ) and nefazodone significantly decreased, while Mirtazapine ( Remeron ) increased the activity of the enzyme. A one-day treatment with antidepressants caused a significant decrease in the CYP2D activity after imipramine, Fluoxetine ( contraceptives Prozac ) and Sertraline HCL ( Zoloft ). Inhibition and possible induction of rat CYP2D after short- and long-term treatment with antidepressants.The aim of this look sharp was to investigate the influence of tricyclic antidepressants (imipramine, Amitriptyline ( Elavil ), clomipramine, desipramine), selective serotonin reuptake inhibitors (SSRIs. Antagonism studies carried out with betaxolol for those drugs that fully generalized to isoproterenol's cue verified mediation by beta1-adrenergic receptors. sleeping pills The present results indicate that drugs with noradrenergic activity generalize to isoproterenol's discriminative stimulus. Clomipramine (K(i) 14 microM) > Sertraline HCL ( Zoloft )approximate, equals Fluoxetine ( Prozac ) (K(i) 17 and 16 microM, respectively) > imipramine approximate, equals Amitriptyline ( Elavil ) (K(i) 26 and 25 microM, respectively) > desipramine (K(i) 44 microM) > nefazodone (K(i) 55 microM) > Mirtazapine ( Remeron ) (K(i) 107 microM). Firstly, competitive inhibition of CYP2D shown in-vitro, the inhibitory effects of tricyclic antidepressants and SSRIs being stronger than those of novel drugs; secondly, in-vivo inhibition of CYP2D produced by both one-day and chronic treatment with tricyclic antidepressants (except for desipramine and clomipramine) and SSRIs, which suggests inactivation of the enzyme apoprotein by reactive metabolites; and thirdly, in-vivo inhibition by nefazodone and induction by Mirtazapine ( Remeron ) of CYP2D produced only by chronic treatment with the drugs, which suggests their influence on the enzyme regulation.. The reaction was studied in control liver microsomes in the presence of the antidepressants, as well as in microsomes of rats treated intraperitoneally for one day or two weeks (twice a day) with pharmacological doses of the drugs (imipramine, Amitriptyline ( Elavil ), clomipramine, nefazodone 10 mg kg(-1) i.p.; desipramine, Fluoxetine ( Prozac ), Sertraline HCL ( Zoloft )5 mg kg(-1) i.p.; Mirtazapine ( Remeron ) 3 mg kg(-1) i.p.), in the absence of the antidepressants in-vitro. Antidepressants decreased the activity of the rat CYP2D by competitive inhibition of the enzyme, the potency of their inhibitory effect being as follows. The serotonin uptake inhibitor Fluoxetine ( Prozac ), the atypical antidepressants buspirone and trazodone, and the novel, putative antidepressants N(G)-nitro-L-arginine and N-acetyl-L-tryptophan 3,5-bis benzyl bettine failed to substitute for isoproterenol at the dose ranges tested. The tricyclic antidepressants protriptyline and desipramine, the norepinephrine uptake inhibitor nisoxetine, the monoamine oxidase inhibitor phenelzine, and the atypical antidepressants Bupropion ( Wellbutrin SR ), Mirtazapine ( Remeron ), and Venlafaxine ( Effexor ) all produced greater than 90% isoproterenol-appropriate responding. In the present study, this model was used to sift the ability of antidepressant drugs displaying various pharmacological profiles to stimulate beta1-adrenergic receptors in vivo; this was assessed by determining whether they substituted for the discriminative stimulus effects of isoproterenol.
|